Home / Financial Report / Leidos Tops Wall Street’s Full 2015 & 4Q Earnings Forecasts

Leidos Tops Wall Street’s Full 2015 & 4Q Earnings Forecasts

LeidosLogoLeidos Holdings (NYSE: LDOS) — one of 30 companies listed in Executive Mosaic’s GovCon Index — has reported earnings of $2.78 per share for its full 2015 calendar year to exceed the consensus Wall Street forecast by 2 cents.

The Reston, Virginia-based government services contractor stated full-year net income as $254 million compared to the $323 million loss posted in 2014 and fourth quarter profit came in at $127 million to show a nearly three-fold increase from $44 million stated for the same period in 2014.

Full 2015 revenue totaled $5.08 billion and fourth quarter sales were $1.28 billion with both figures relatively flat from the prior year periods.

Leidos’ fiscal year 2016 guidance has the company’s earnings in a range of $2.75-to-$2.95 per share and revenue of between $5.1 billion and $5.3 billion, with the sales forecast not including outlooks related to the company’s merger with Lockheed Martin‘s (NYSE: LMT) government services businesses.

As of Wednesday’s close, shares in Leidos had declined 21.33 percent from the year’s start and were flat over 12 months.

Check Also

F5 to Buy Shape Security for $1B; Francois Locoh-Donou Quoted

F5 Networks (Nasdaq: FFIV) has agreed to acquire Santa Clara, Calif.-based Shape Security for approximately $1B in cash as both companies aim to help government and enterprise customers secure digital experience with integrated offerings.

Paratek Secures $169M Anthrax Antibiotic Development Contract Under HHS Project BioShield

The Department of Health and Human Services has awarded Paratek Pharmaceuticals a potential a five-year, $169M contract to further develop an antibiotic drug as a potential treatment for inhalation anthrax.